Study Funding: Supported by grants from the University of Copenhagen, The Danish Headache Society and through The Lundbeck Foundation Center for Neurovascular Signalling (LUCENS).
Calcitonin Gene-Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine
Article first published online: 1 APR 2011
© 2011 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 51, Issue 4, pages 544–553, April 2011
How to Cite
Hansen, J. M., Thomsen, L. L., Olesen, J. and Ashina, M. (2011), Calcitonin Gene-Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine. Headache: The Journal of Head and Face Pain, 51: 544–553. doi: 10.1111/j.1526-4610.2011.01861.x
Conflict of Interest: Dr. Hansen and Dr. Thomsen report no disclosures. Dr. Olesen serves on scientific advisory boards for Allergan Inc., AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen, MSD, Pfizer Inc, Minster Pharmaceuticals plc, ROXRO PHARMA, MAP Pharmaceuticals, NeurAxon, Inc., and Lundbeck Inc.; serves on speakers' bureaus for Allergan Inc., AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen, MSD, Pfizer Inc, Minster Pharmaceuticals plc, ROXRO PHARMA, MAP Pharmaceuticals, NeurAxon, Inc., and Lundbeck Inc.; and receives research support from Lundbeck Inc. Dr. Ashina serves on scientific advisory boards and as a consultant for MSD, BTG plc, and Allergan, Inc.; has received funding for travel from MSD; serves as an Associate Editor of the Scandinavian Journal of Pain and on the editorial advisory board of The Journal of Headache and Pain; and serves on speakers' bureaus for and received speaker honoraria from MSD, Pfizer Inc, GlaxoSmithKline, Norpharma, and AstraZeneca.
- Issue published online: 1 APR 2011
- Article first published online: 1 APR 2011
- Accepted for publication December 25, 2010.
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.